Prostate cancer is Australian most steadily diagnosed cancer. One in six men might be diagnosed before the age of 85.

Cancers are abnormal groups of cells that grow uncontrollably and start to invade nearby areas. They may also spread to other organs in the body. This is called metastasis.

Treatment of early-stage disease, when the cancer is confined to the original site, focuses on that single area, most frequently with surgery or radiation therapy. Treating advanced disease once it has spread often relies on whole-body treatments similar to chemotherapy or immunotherapy.

A more advanced form of radiation therapy, called stereotactic ablative radiation therapy, may be effective in treating each early and advanced cancers. How does it work? And how does this relate to existing therapies?

Delivers a better dose to a smaller goal

Stereotactic radiotherapy uses high doses of radiation to goal and kill cancer cells. It uses newer machines that may deliver very focused beams of radiation. Combined with advances in imaging and radiotherapy planning software, this enables clinicians to “track” and goal tumors.

This ensures such high precision – with targeting accuracy of lower than 1 mm – that cancers may be safely treated with minimal risk of damage to surrounding healthy organs.

Having a better dose signifies that radiation therapy may be delivered in fewer treatments (one to five sessions over one to two weeks), whereas previously it was divided into many small doses (20 to 40) given over weeks and even months.

Stereotactic radiotherapy is increasingly used in cancer treatment brain AND lungs. However, latest data has shown that it may also effectively treat prostate cancer.

What did the latest study show?

AND test published this month in the New England Journal of Medicine compared two groups of patients with early prostate cancer whose median age was 69.8 years. Half (433 participants) received five sessions of stereotactic radiotherapy, the other half (431 participants) received standard radiotherapy consisting of at the least 20 sessions.

The researchers found no long-term differences in outcomes between the groups – 95% of patients showed no symptoms of the disease five years after treatment. These cure rates are there equivalent in patients who’ve had their prostate surgically removed.

Early evidence suggests that stereotactic radiotherapy appears to be as effective, less burdensome, and fewer invasive than currently available treatment options.

Prostate cancer that has spread beyond its original site is unlucky incurable in most cases. Treatment of this stage of the disease is aimed toward stopping or controlling the cancer for so long as possible.

However, studies demonstrated that stereotactic radiotherapy may be used to treat disease that has spread to distant sites in patients with advanced prostate cancer. Researchers have found that stereotactic radiation therapy can free patients from clinically apparent disease for 8 to 13 months, delaying the need for hormone therapy or chemotherapy.

What are the unwanted side effects compared to other cancer treatments?

Stereotactic radiotherapy with painless radiation beams is performed every single day. In the weeks after delivery, it is common to notice soreness and/or inflammation in the treated area. This reaches the level of requiring treatment one third of the cases.

Treatment for prostate cancer often affects erectile function because the nerves and blood vessels chargeable for erection are sometimes damaged.

Other recent research comparing stereotactic radiotherapy with surgery, it was found that 48% of patients treated with stereotactic radiotherapy had problems with sexual function two years after treatment compared with 75% of patients who underwent surgery.

What are the costs? Who can access it?

Newer AND more advanced Radiation therapy machines can provide more precise treatment, but they’re rather more expensive than standard machines. They even have more complex maintenance and operational requirements.

However, traditional radiation therapy devices can be improved to provide stereotaxic precision.

Although the initial investment costs could also be high, the cost-benefit ratio exercise show that stereotactic radiotherapy for lung cancer costs the healthcare system lower than other cancer treatments and traditional radiotherapy. This is partly because treatment ends much faster. Formal cost-benefit analyzes haven’t been performed for prostate cancer, but they’re likely to be similar.

Stereotactic radiotherapy is now widely available in most major Australian public hospitals for the treatment of many varieties of cancer, including chosen lung cancers, kidney cancers, advanced brain cancers and bone cancers. This is without charge to patients. It is also provided in many private centers.

However, even when a middle can provide stereotactic radiotherapy, there is still significant variation in the equipment used to deliver this therapy.

Furthermore, the actual planning and delivery of radiotherapy is a fancy skill. Studies they showed that patients treated by clinicians with higher case volumes have higher outcomes due to greater familiarity with these specialized techniques.

Over the past few years, radiotherapy departments around the world have rapidly expanded their capability to provide stereotactic radiotherapy. Following the results of recent clinical trials, prostate cancer will most certainly be added to the list of cancers treated in this fashion.

“; } }); // Drag and scroll functionality const playlistContainer = document.getElementById(‘playlist’); let isDown = false; let startY; let scrollTop; playlistContainer.addEventListener(‘mousedown’, (e) => { isDown = true; playlistContainer.classList.add(‘active’); startY = e.pageY – playlistContainer.offsetTop = playlistContainer.addEventListener(‘mouseleave’; playlistContainer.classList.remove(‘active’); playlistContainer.addEventListener(‘mouseup’, () => { isDown = false; playlistContainer.classList.remove(‘active’); }); mousemove’, (e) => { if (!isDown) return; e.preventDefault(); const y = e.pageY – playlistContainer.offsetTop; const walk = (y – startY) * 3; .scrollTop = scrollTop – walk; }); } } if (” !== ‘efoc24’) { // Check DoubleVerify Quality Targeting signals before rendering the player if ( ‘unknown’ !== typeof PQ ) { PQ.cmd. push(function() { // If DVQT signals are not available after 500 ms, render the player anyway. const timeout_id = setTimeout( jwPlayerRender, 500 ); // Get “Authentic Direct” signals. PQ.getTargeting({ signals: [‘abs’] }, function(error, targetingData) { clearTimeout(timeout_id); jwPlayerRender(error? undefined: targetingData); }); }); } else { jwPlayerRender(); } function jwPlayerRender( dvqt_signals=”” ) { let jw_ad_tag ​​= {“client”:”googima”,”adscheduleid”:”G7hR9pQ2″,”schedule”:[{“tag”:”https://pubads.g.doubleclick.net/gampad/ads?correlator=&iu=/21698916284/ess/VideoNews&env=vp&gdfp_req=1&output=vast&sz=400×300%7C640x480%7C1000x1%7C1920x1080&description_url=__page-url__&tfcd=0&npa=0&vpmute=1&vpa=auto&vad_type=linear&url=__page-url__&vpos=preroll&unviewed_position_start=1&v=qo2NVKpu&pmnd=0&pmxd=60000&ad_rule=1&cust_params=ttid%3Dqo2NVKpu%26frnch%3D__item-franchise__%26environment%3Dproduction%26kwblock%3DAbb%2CCapOne%2CLincoln%2CUPS%2CVG%2CATTCric%2CDisney”,”offset”:”pre”},{“tag”:”https://vid.springserve.com/vast/670880?url=https://www.essence.com/news/watch-black-women-in-the-news-heres-how-kristen-welker-meets-the-moment-as-moderator-of-meet-the-press/h=450&w=800&cb=1758″,”offset”:”50%”}]”offers”:{“bidders”:[{“id”:”jw-video-qo2NVKpu”,”name”:”jwdemand”,”publisherId”:”evcxFIDZ”,”siteId”:”WT5iFegj”,”placementId”:”24399785″}]”settings”:{“disableConsentManagementOnNoCmp”:true,”mediationLayerAdServer”:”dfp”,”floorPriceCents”:200,”floorPriceCurrency”:”usd”,”buckets”:[{“increment”:0.1,”max”:30,”min”:0},{“increment”:0.5,”max”:50,”min”:30}]}}}; // Configure ad tag on the fly… let additional_params = {}; // Input DVQT signals. if ( dvqt_signals && dvqt_signals.ABS.length > 0 ) { additional_params.ABS = dvqt_signals.ABS.join(“,”); } // Injecting Operational Mage signals. if ( ps_ad_object && ps_ad_object[0].page_targeting.length > 0 ) { let ad_targeting = JSON.parse(ps_ad_object[0]page targeting); if ( ad_targeting.opsmage && ad_targeting.opsmage.length > 0 ) { additional_params.opsmage = ad_targeting.opsmage.join(“,”); } if ( ad_targeting.opsmage_alt && ad_targeting.opsmage_alt.length > 0 ) { additional_params.opsmag_alt = ad_targeting.opsmage_alt.join(“,”); } } // Create a string additional_parameters. let extra_params_str=””; for (enter additional_parameters) { let value = additional_parameters[key]; additional_params_str += `${key}=${value}`; if ( key !== Object.keys( additional_params .pop() ) { additional_params_str += ‘&’; } } // Update ad tag cust_params (must be URL encoded). if ( Object.keys( additional_parameters ). length > 0 ) { let ad_schedule = jw_ad_tag.schedule; if ( ‘undefined’ !== ad schedule type ) { for (let i = 0; i < ad_schedule. length; i++) { let ad_url = new URL(jw_ad_tag. schedule[i].label); let query_params = new URLSearchParams(ad_url.search); query_params.set("cust_params", query_params.get("cust_params") + `&${additional_params_str}`); ad_url.search = query_params.toString(); jw_ad_tag.schedule[i].tag = ad_url.toString(); } } } let playerId; if ("undefined" !== type jwplayerQueue) { playerId = 'jw-video-qo2NVKpu'; jwplayerQueue.push({ 'instanceId': 'playerInstance_qo2NVKpu', 'playerId': playerId, 'config': { pid: 't6KP9zcV', playlist: "https://cdn.jwplayer.com/v2/media/qo2NVKpu", autostart: !jw_ad_tag, repeat: true, mute: true, aspect ratio: "16:9", share: {sites: ["facebook", "twitter", "email", "linkedin"]}, cast: {}, float: {disibility: true}, autoPause: {viewability: true}, displaytitle: true, displaydescription: true, controls: true, related: {displayMode: 'shelfWidget'}, interactive: {} , ad: jw_ad_tag ​​​​} }); } // Load video. jQuery(window).trigger("jw:loadplayers"); function waitForJWPlayer(callback) { if (type jwplayer !== 'undefined') { callback(); } else { setTimeout(function() { waitForJWPlayer(callback); }, 500); } } waitForJWPlayer(function() { jwplayer(playerId).on('adsManager', function (adsManagerLoaded) { let adsManager = adsManagerLoaded.adsManager; let videoElement = document.getElementById(playerId ); let config = { anId: '929481' , campId: '640x360', ias_xps: "autoplay", // autoplay state ias_xbp: "2", // video destination type ias_xar: "1" // autoplay state } // Start IAS integration googleImaVansAdapter. init(google, adsmanager, videoitem, config } } });

Solange Knowles revealed that she is a member of “spoons”communities, people affected by chronic diseases equivalent to autoimmune diseases.

The 38-year-old musician was diagnosed with POTS, Sjogrens and MCAS in 2018. She revealed this in a recent comment she left under the post by model and musician Shaun Ross about her experiences with long Covid.

“Shaun, sending so much love and strength to you and to everyone in the comments who is struggling with the debilitating, confusing and lonely symptoms of POTS,” Knowles wrote.

In the video, 33-year-old Ross explains that consequently of a protracted course of Covid-19, he developed POTS syndrome. He decided to finally share his recovery journey after comments from others about his weight and hopefully help not less than one person scuffling with the results of Covid-19.

In her response, Knowles added: “I was diagnosed with POTS, Sjogrens and MCAS in 2018 and I really don’t want your health to be your identity.”

She continued, “The good people at (Dysautonomia International) have been a truly amazing resource for me and I am truly grateful for their help. spoons community for keeping me alive in moments of complete uncertainty! Sending lots of love your way.”

Featured Stories

According to Cleveland ClinicPOTS, or postural tachycardia syndrome, is a chronic condition that could cause a number of symptoms when an individual sits or stands up, including an abnormally fast heartbeat, dizziness, and fatigue.

Meanwhile, in my view Mayo ClinicSjogren’s syndrome is a chronic autoimmune disease that causes the body’s moisture-producing glands to malfunction, often leading to dry eyes and dry mouth. This condition can often lead to the event of other diseases, including rheumatoid arthritis and lupus. Although the “Cranes in the Sky” singer developed the disease in her 30s, it often affects women of their 40s.

According to the definition a American Academy of Allergy and ImmunologyMCAS, short for mast cell activation syndrome, is a condition that causes an individual to experience repeated severe allergic reactions.

The Knowles organization shouted: International dysautonomyis a charity that funds research and works to improve the lives of individuals with dysautonomia. According to Cleveland Clinicit’s a disorder of the nervous system that interferes with the body’s autonomic processes, equivalent to blood pressure and heart rate.

Although autoimmune disorders can affect many alternative people from all walks of life, disproportionately affect womenwho constitute roughly 4 out of five diagnosed people. Black Americans may not develop all autoimmune diseases at the identical rate as other races, although severe cases and complications affect blacks at a disproportionate rate. As for Sjogrens, for instance, a condition that leads to lymphoma or cancer of the bloodstream within the body it’s more common in black Americans.

Since Knowles opened up about her health journey, many of her friends have praised her and offered their support. under Instagram post by the Sjogens Foundation, thanking her for speaking out, several people commented on how excited they were to hear one other famous face speak out about chronic disease.

“I like it when celebrities admit they’ve an autoimmune disease or Sjogren’s disease. It really helps us not feel alone in our struggles,” wrote one user.

Venus Williams is one other famous black woman who talked about living with this disease. Black women with the condition particularly appreciate the representation of celebrities with the condition.

Another user commented, “That’s great, coming from someone (who) had to fight rheumatologists who told me that black women don’t get Sjogren’s, they get lupus.”